RESMED INC. COMMON STOCK

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

30 Sep 2024 05:10:28 By Nasdaq GlobeNewswire

ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

30 Sep 2024 05:01:00 By Nasdaq GlobeNewswire

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

10 Sep 2024 13:05:00 By Nasdaq GlobeNewswire

Vaping Expected to Increase COPD Health and Economic Burden by 2050

10 Sep 2024 05:01:12 By Nasdaq GlobeNewswire

NetDania - New 12 months High: RESMED INC. COMMON STOCK

09 Sep 2024 06:45:18 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

03 Sep 2024 06:50:10 By NetDania Notify

ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

28 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: RESMED INC. COMMON STOCK

28 Aug 2024 07:44:29 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

27 Aug 2024 06:52:49 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

19 Aug 2024 06:47:38 By NetDania Notify

ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board

15 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: RESMED INC. COMMON STOCK

15 Aug 2024 10:21:55 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

02 Aug 2024 09:19:22 By NetDania Notify

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

01 Aug 2024 13:05:01 By Nasdaq GlobeNewswire

ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024

03 Jul 2024 13:05:00 By Nasdaq GlobeNewswire

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

10 Jun 2024 06:05:00 By Nasdaq GlobeNewswire

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

23 May 2024 06:05:00 By Nasdaq GlobeNewswire

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

16 May 2024 13:35:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the RBCCM Global Healthcare Conference

07 May 2024 13:05:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

25 Apr 2024 13:05:01 By Nasdaq GlobeNewswire